
Adexone S 1000mg/500mg Injection
Marketer
Adelina Lifesciences
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Adexone S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial. Complete the entire treatment course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; escalating symptoms warrant immediate medical attention. Seek emergency care for allergic reactions (e.g., rashes, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Primary Ingredients of Adexone S 1000mg/500mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Adexone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Adexone S 1000mg/500mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Adexone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Adexone S 1000mg/500mg Injection:
This medication will be administered by your physician or their associate; self-medication is strongly discouraged.
How Adexone S 1000mg/500mg Injection works:
Adexone S injection (1000mg Ceftriaxone/500mg Sulbactam) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Adexone S 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Adexone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Adexone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Adexone S 1000mg/500mg Injection might induce drowsiness, blurred vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Adexone S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Adexone S 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Adexone S 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Adexone S 1000mg/500mg Injection :
Should you forget a scheduled dose of Adexone S 1000mg/500mg Injection, seek medical advice.
Facts to Know About Adexone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
